Redefining the Value Proposition of Precision Oncology

This commentary discusses a cohort study of patients with non–small cell lung cancer published in JAMA that compares clinical outcomes following broad-based genomic sequencing vs routine testing for EGFR mutations and/or ALK mutations.

https://ift.tt/2MAk6kY